<DOC>
	<DOCNO>NCT01363999</DOCNO>
	<brief_summary>A single-center , crossover study evaluate pharmacokinetics dalcetrapib atorvastatin prototype fix dose combination formulation healthy volunteer . Volunteers receive single dose dalcetrapib atorvastatin four treatment period .</brief_summary>
	<brief_title>A Formulation Screening Study Dalcetrapib Atorvastatin Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Dalcetrapib</mesh_term>
	<criteria>Healthy volunteer , 18 55 year age , inclusive Any concomitant disease ongoing condition investigator 's opinion could interfere study could pose unacceptable risk patient Clinically significant abnormal laboratory value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>